María C Ovejero-Benito

Profesora Colaboradora Doctora

Universidad CEU San Pablo

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

María C Ovejero-Benito is a Profesora Colaboradora Doctora at Universidad CEU San Pablo in Spain. Her research focuses on genetic polymorphisms related to psoriasis and pharmacogenetic biomarkers impacting treatment responses in real-life clinical settings. Additionally, she investigates neurogenesis and drug resistance in epilepsy, as well as the pharmacogenetics of various medications. Her recent work includes studies on DNA methylation and the regulation of inflammatory markers in psychiatric disorders.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

SPAIN

View details

Alfonso Lagares

Associate Professor Neurosurgery

Universidad Complutense de Madrid Facultad de Medicina

SPAIN

View details

Marta Vicente-Rodríguez

Profesora Farmacología

Universidad CEU San Pablo

SPAIN

View details

Maria F. Cano-Abad

Associate Professor

Universidad Autónoma de Madrid

SPAIN

View details

Julio Sevillano

FULL PROFESSOR OF BIOCHEMISTRY AND MOLECULAR BIOLOGY

Universidad CEU San Pablo

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

María C Ovejero-Benito

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Genetic Polymorphisms in Psoriasis: Investigating Genetic Variations for Precise Profiling of Response to Brodalumab in Real-Life Clinical Practice

Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real‐life clinical practice

Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practice.

Receptor protein tyrosine phosphatase β/ζ regulates loss of neurogenesis in the mouse hippocampus following adolescent acute ethanol exposure

Neuronal and astrocytic tetraploidy is increased in drug‐resistant epilepsy

DNA Methylation Description of Hippocampus, Cortex, Amygdala, and Blood of Drug-Resistant Temporal Lobe Epilepsy

Extensive pharmacokinetic variability of Levetiracetam. ¿Are doctors aware?

CNVs Associated with Different Clinical Phenotypes of Psoriasis and Anti-TNF-Induced Palmoplantar Pustulosis

Pharmacogenetics of Donepezil and Memantine in Healthy Subjects

Pharmacokinetic variability of eslicarbazepine in real clinical practice

Intracellular calcium and inflammatory markers, mediated by purinergic stimulation, are differentially regulated in monocytes of patients with major depressive disorder

ABCB1 C3435T, G2677T/A and C1236T variants have no effect in eslicarbazepine pharmacokinetics.

Growth arrest and DNA damage-inducible proteins (GADD45) in psoriasis.

Collaborators (10)

Pilar Lopez-Garcia

Lola Fernández-Messina

Francisco Abad-Santos

PAULA DE TOLEDO

Maria P. Ramos-Alvarez

Yolanda Sánchez

Alfonso Lagares

Marta Vicente-Rodríguez

Maria F. Cano-Abad

Julio Sevillano

Make your next move.